EFFICACY AND SAFETY OF RITUXIMAB IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

被引:0
作者
Ren, Y. [1 ,2 ]
Wang, L. [2 ]
An, Z. [2 ]
Yang, L. [2 ]
Su, Q. Y. [2 ,3 ]
Yu, Q. [4 ,5 ]
He, P. F.
Li, X. [3 ]
Zhang, S. X. [1 ,2 ]
机构
[1] Shanxi Med Univ, Minist Educ, Key Lab Cellular Physiol, Taiyuan, Peoples R China
[2] Shanxi Med Univ, Acad Mircobial Ecol, Taiyuan, Peoples R China
[3] Shanxi Med Univ, Hosp 2, Dept Rheumatol, Taiyuan, Peoples R China
[4] Shanxi Med Univ, Shanxi Key Lab Big Data Clin Decis Res, Taiyuan, Peoples R China
[5] Shanxi Med Univ, Key Lab Big Data Clin Decis Res, Taiyuan, Peoples R China
关键词
Systemic lupus erythematosus;
D O I
10.1136/annrheumdis-2023-eular.4279
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
AB0559
引用
收藏
页码:1477 / 1477
页数:1
相关论文
共 1 条
[1]   Belimumab and Rituximab in Systemic Lupus Erythematosus: A Tale of Two B Cell-Targeting Agents [J].
Wise, Leanna M. ;
Stohl, William .
FRONTIERS IN MEDICINE, 2020, 7